14:55 | 17.12.2008
Senetek PLC Announces 2008 Annual General Meeting Voting Results
NAPA, California, December 17 /PRNewswire/ —
Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged
in the development of technologies that target the science of healthy aging,
today announced that shareholders have approved all four resolutions that the
Company had proposed at the Annual General Meeting of Shareholders held on
December 16, 2008.
“We are pleased with the results of the voting and we thank our
shareholders for their support,” stated Frank J. Massino, Chairman & CEO of
Senetek. “The Board and management of Senetek are looking forward to a
productive and successful year in 2009.”
About Senetek PLC
Senetek PLC (OTCBB: SNKTY) is a Life Sciences company engaged in the
development of breakthrough technologies that target the science of healthy
aging. The Company’s extensive research collaborations have resulted in a
strong pipeline of patented compounds and products with broad therapeutic
applications and a leading presence in dermatology. Senetek collaborates with
established specialty pharmaceutical companies in the final development and
marketing of its proprietary products, most recently resulting in the
development of the best-selling anti-aging product sold in the North American
physician market. For more information, visit the company’s website at
http://www.senetekplc.com.
This news release contains statements that may be considered
‘forward-looking statements’ within the meaning of the Private Securities
Litigation Reform Act. Forward-looking statements by their nature involve
substantial uncertainty, and actual results may differ materially from those
that might be suggested by such statements. Important factors identified by
the Company that it believes could result in such material differences are
described in the Company’s Annual Report on Form 10-K for the year 2007.
However, the Company necessarily can give no assurance that it has identified
or will identify all of the factors that may result in any particular
forward-looking statement materially differing from actual results, and
the Company assumes no obligation to correct or update any forward-looking
statements which may prove to be inaccurate, whether as a result of new
information, future events or otherwise.
Senetek PLC
William O’Kelly of Senetek PLC, +1-707-226-3900, ext. 102
|
